Aurinia Pharmaceuticals Inc.

(AUP:CA)

By |

Profile

Aurinia Pharmaceuticals Inc is a clinical stage pharmaceutical company. Its focused on the development of its novel therapeutic immunomodulating drug candidate, voclosporin, for the treatment of lupus nephritis.

Contact Information

Website: www.auriniapharma.com
Main Phone: +1 250 708-4272
Address: 4464 Markham Street
Address 2: Suite 1203
State: BC
City / Town: Victoria
Country: CAN
Postal Code: V8Z 7X8

Issuer Information

Exchange: TSX
Employees: 16
NAICS: Pharmaceutical P
$ 3.83 ($ 0.12) (-3.04%)
Last Price 3.83 Change $ -0.12 Change % -3.04 Tick N/A
Bid 3.80 Bid Size 5,700.00 Ask 3.92 Ask Size 300.00
Open 4.09 High 4.09 Low 3.77 Prev Close 3.95
Last Trade Volume 65,453 52 Wk Hi 7.50 52 Wk Low 2.23
Market Cap 152.2 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 39,727,206.00 EPS (TTM) -0.76 PE Ratio N/A Exchange TSX
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 10.89 10.89 10.89 10.89
Low Target Price Estimate 10.89 10.89 10.89 10.89
Mean Target Price Estimate 10.89 10.89 10.89 10.89
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 03/29/16 03/29/16 03/29/16 03/29/16
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 0 0 0 1